Beradio, Javelene Q.

HRN: 03-68-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/20/2022
IV
1.5g
Q8
T/C UTI
09/19/2022
CEFUROXIME 500MG (TAB)
09/21/2022
09/28/2022
PO
500mg
Q12
T/C UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: